Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Innovative Immunodiagnostic Platform Unveils Highly Sensitive Cancer…
Instead of hunting for tiny fragments of circulating tumour DNA, the platform measures fluctuations in specific amino acid residues - building blocks of immune proteins - in a simple blood sample. Instead of hunting for tiny fragments of circulating tumour DNA, the platform measures fluctuations in specific amino acid residues - building blocks of immune proteins - in a simple blood sample. Early-stage tumours often provoke a robust immune response before they shed enough DNA to be detected...
PR Newswire
15/07/2025
The New Science of Superhumans: The BioSport™ AI System Unlocks Hidden Athlete…
With elite advisors, cutting-edge genomics, and real-time AI, the sports health platform targets cardiac complications, overexertion injuries, flawed team selections, and untapped talent In the high-stakes world of elite sports, the difference between triumph and tragedy can hinge on a single, unseen biological flaw. A hidden cardiac risk. A lingering inflammation. A genetic predisposition to injury. These silent threats have ended promising careers and lives—sometimes on live television,...
Nasdaq GlobeNewswire
15/07/2025
Oral Care Market worth $53.29 billion by 2030 with 6.4% CAGR |…
Browse in-depth TOC on 'Oral Care Market'345 - Tables62 - Figures318 - Pages Browse in-depth TOC on 'Oral Care Market' 345 - Tables 62 - Figures 318 - Pages By product type,the oral care market can be categorized by product type into several key segments, including toothpaste, toothbrushes, mouthwashes/rinses, dental accessories, and denture products. As of 2024, the toothpaste segment dominated the market, capturing the largest share. This significant market presence can be...
PR Newswire
15/07/2025
Evestia Clinical to merge with Atlantic Research Group
Kester Capital-backed Evestia Clinical merges with US-based Atlantic Research Group (ARG) to create a leading independent global specialist CRO in fast-growing marketsThe merger delivers on Evestia Clinical’s strategy of targeted growth through the expansion of services, enhanced technology and broadened geographical reachEvestia Clinical expands footprint in the US and strengthens its offering beyond oncology, rare diseases, immunology and inflammation to include neurology and...
Nasdaq GlobeNewswire
15/07/2025
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy…
Media.Market.us continued: "Enhanced Patient Monitoring through AI: AI-powered tools are revolutionizing the monitoring of retinal diseases. These tools enable continuous observation, allowing doctors to track disease progression over time. This ongoing monitoring is crucial for chronic conditions, where timely adjustments to treatment can lead to better management of the disease. Continuous data collection provided by AI tools offers a dynamic view of the patient's condition, facilitating…
PR Newswire
15/07/2025
AAVantgarde Receives FDA Clearance to Progress Stargardt Disease Asset…
AAVB-039 delivers the full-length ABCA4 -protein, addressing the root cause of the disease and enabling treatment of all patients, independent of mutationCELESTE is informed by the STELLA prospective natural history study, which is currently enrolling patients in the United States and EuropeAAVB-039 uses AAVantgarde’s proprietary dual AAV intein platform. The platform has achieved unprecedented preclinical data demonstrating high transduction, protein expression, and safety in...
Nasdaq GlobeNewswire
15/07/2025
Elsevier's Clinician of the Future 2025 survey: Clinicians' AI usage and…
Physicians and nurses are optimistic about the potential of AI to improve patient care in the next two to three years. Based on 2,206 survey responses from 109 countries, clinicians are most optimistic about the potential of clinical AI tools to save them time (70%), enhance diagnostic speed (58%) and accuracy (54%), and help improve patient outcomes (55%). Physicians and nurses are optimistic about the potential of AI to improve patient care in the next two to three years. Based on 2,206...
PR Newswire
15/07/2025
Navamedic ASA: Closing of the transaction to acquire the business of dne pharma
The Acquisition encompasses dne pharma's business, including product portfolio, key employees and all essential contracts of the business, intellectual property, licenses, and distribution agreements. The product portfolio includes prominent products such as Ventizolve® (intranasal naloxone spray for opioid overdose reversal), Levopidon® (levomethadone), and Metadon Dne (methadone) for opioid substitution therapy. The acquired business will be integrated into Navamedic's existing commercial…
PR Newswire
15/07/2025
Bridge to Life™ Unveils Groundbreaking 12-Month Clinical Trial Data on HOPE at…
The following are scheduled presentations at WTC 2025: The following are scheduled presentations at WTC 2025: Plenary SessionPresentation Title:Hypothermic-Oxygenated and Normothermic Machine Perfusion: A Risk-Matched Post-Hoc Comparison of the Bridge to Hope Randomized Trial with Prospectively Collected Institutional OutcomesDate: Monday, August 4 th Time:10:30 AM -10:45 AM PT Presenter: Chase J. Wehrle, MD, Cleveland Clinic,Cleveland, OH ILTS 2025 Young Investigators...
PR Newswire
15/07/2025
New TriNetX Survey Reveals Biopharma's Bold Embrace of Real-World Data and…
The survey, which polled 150 senior executives across pharma and biotech, found that: The survey, which polled 150 senior executives across pharma and biotech, found that: "Real-world data is no longer a concept, it's a capability," saidSteve Kundrot, Chief Operating Officer at TriNetX. "The leaders we surveyed see its value and are investing in execution. But to fully realize real-world data's promise, we must tackle integration challenges, enforce data standards, and build trust…
PR Newswire
15/07/2025
Argon Medical Streamlines Distribution of Product and Enhances Customer Training…
This major investment underscores Argon Medical's commitment to enhancing customer service, operational excellence, and clinical support amid the rapid growth of the EMEA and APAC markets. By streamlining logistics and providing comprehensive education, the new facility is poised to accelerate product shipments, increase responsiveness, and foster stronger, more collaborative partnerships with regional stakeholders. This major investment underscores Argon Medical's commitment to enhancing...
PR Newswire
15/07/2025
Lunar Mineralogram: Daphne Lab® Unveils AI-Powered Bioenergetic Test for…
Daphne Lab® introduces the Lunar Mineralogram, a revolutionary update to its bioenergetic analysis platform, developed within the framework of the Lunar Project. The new test features advanced AI-driven indicators, novel toxicological profiles, and cutting-edge algorithmic processing. Key innovations include the IBR (Isotopic Balance Ratio) and EMPI (Electrometallopathy Index), along with a broadened panel of trace elements.
Daphne Lab
15/07/2025
Esaote North America, Inc. Honored at Premier, Inc.'s Annual Supplier Innovation…
"It's an honor to have the O-scan SMART recognized as an Innovation Celebration award winner," says Stephen Gibbs, Director of Sales and Marketing at Esaote North America, Inc. "Adding extremity MRI to your imaging services offers a smart, cost-effective investment. With lower installation and operating costs compared to conventional systems, extremity MRI helps facilities reduce patient backlogs, control costs, and expand access to care to everyone, everywhere." "It's…
PR Newswire
15/07/2025
Gen Phoenix Secures $15M Investment Round as Tapestry Expands Strategic…
"This expanded partnership marks a major milestone—not just for Gen Phoenix, but for the future of sustainable materials," said John Kennedy, CEO of Gen Phoenix. "Together with Tapestry, we're proving that circular innovation can meet the demands of global brands without compromise. It's a powerful example of what happens when you combine material innovation, leather heritage, shared values, and a commitment to scale." "This expanded partnership marks a major…
PR Newswire
15/07/2025
Second Edition of Ketamine-Assisted Therapy Training in Barcelona
The Ketamine Research Foundation (USA) and Clínica Synaptica present the second edition of the Ketamine-Assisted Psychotherapy (KAP) Training, a pioneering program in Europe that strengthens an innovative mental health approach already established in the USA and Canada. KAP, which combines ketamine administration with psychotherapy, is transforming the treatment of disorders such as treatment-resistant depression, anxiety disorders, post-traumatic stress disorder, and chronic pain by inducing…
PR Newswire
15/07/2025
Baraya Extended Care Closes Series B Funding Round Bringing Total Capital Raised…
This fundraise comes at a critical moment, as Saudi Arabia faces a rapidly aging population, rising incidences of chronic conditions, and increased demand for specialized post-acute care driven by the Kingdom's ambitious Vision 2030 and Health Sector Transformation Program. According to the Saudi Ministry of Health, 14% of acute care beds in public hospitals are occupied by long-stay (long-term care) patients. This figure is even higher in some regions, such as Jeddah (19%) and Riyadh (17%). ...
PR Newswire
15/07/2025
Topflight Pharma Development Veteran Joins Synendos
Dr. George Garibaldi is named Chief Medical Officer (CMO) as Synendos transitions from Phase 1 into Phase 2 of its clinical development strategy Synendos CEO, Andrea Chicca said, "It’s tremendous that Synendos can attract this calibre of talent and experience. George offers a nuanced clinical perspective on the urgent needs of the patients we are looking to help, combined with specific expertise in advancing transformative neuroscience therapies from concept to clinical adoption.”Dr...
Nasdaq GlobeNewswire
15/07/2025
Da Vinci’s Vitruvian Man Encodes the Blueprint of Human Evolution, Says London…
New research reveals a hidden geometric ratio in Leonardo’s drawing that may define the endpoint of human evolution toward upright posture Photo Courtesy of Rory Mac Sweeney LONDON, July14, 2025(GLOBE NEWSWIRE) -- A London-based dental surgeon and researcher, Dr. Rory Mac Sweeney of Precision Endodontics, has ignited international interest with a provocative reinterpretation of Leonardo da Vinci’s Vitruvian Man. His newly published research suggests the Renaissance masterpiece...
Nasdaq GlobeNewswire
15/07/2025
MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast…
Key Takeaways from the MCR Therapies Market Report Key Takeaways from the MCR Therapies Market Report Discover which indication is expected to grab the major MCR therapies market share @MCR Therapies Market Report MCR Therapies Market Dynamics The MCR therapies market is emerging as a promising therapeutic area, driven byadvancements in understanding melanocortin receptor biologyand its involvement in multiple disease pathways. MCRs, which include five distinct receptor...
PR Newswire
14/07/2025
LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER
"I am thrilled to welcome Mitch to LabConnect and to our leadership team," said Wes Wheeler, LabConnect Chief Executive Officer. "I am confident that his leadership and expertise will play a vital role in driving profitable growth at LabConnect, achieving operational excellence across the enterprise, and advancing our capital allocation priorities." "I am thrilled to welcome Mitch to LabConnect and to our leadership team," said Wes Wheeler, LabConnect Chief…
PR Newswire
14/07/2025
Perfume Ingredient Chemicals Market to Reach USD 11.43 Billion by 2032, Reports…
Browse the report and understand how it can benefit your business strategy-https://www.credenceresearch.com/report/perfume-ingredient-chemicals-market Browse the report and understand how it can benefit your business strategy- https://www.credenceresearch.com/report/perfume-ingredient-chemicals-market Key Growth Determinants – Perfume Ingredient Chemicals Market One of the primary growth drivers for the perfume ingredient chemicals market is the rising global demand for premium,...
PR Newswire
14/07/2025
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II…
Leuven, BELGIUM – July 14, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on July 9, 2025, from Atlas Special…
Actusnews Wire
14/07/2025
Anesthesia Monitoring Devices Market Size expected to reach US$5.93 billion by…
The anesthesia monitoring device market analysis focuses on advancements such as the integration of artificial intelligence (AI) and machine learning and the continuous monitoring of multivariable parameters, which are expected to play a vital role in the market growth in the coming years. The report runs an in-depth analysis of market trends, key players, and future opportunities. The anesthesia monitoring device market analysis focuses on advancements such as the integration of...
PR Newswire
14/07/2025
Respiratory Care Devices Market worth $33.6 billion by 2030 with 7.3% CAGR |…
Browse in-depth TOC on "Respiratory Care Devices Market" Browse in-depth TOC on "Respiratory Care Devices Market" 587 - Tables 63 - Figures 466 - Pages By product type,Therapeutic devices are necessary for managing and treating the majority of acute and chronic respiratory diseases. They are required to provide patients with COPD, asthma, sleep apnea, and respiratory failure with life-sustaining respiratory therapy. The devices include high-flow nasal cannula systems, CPAP...
PR Newswire
14/07/2025
Altri Comunicati